Axsome Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Axsome Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Axsome Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -55.4 %, a 32.8% decline year-over-year.
  • Axsome Therapeutics, Inc. annual Return On Assets for 2023 was -43.7 %, a 45.1% increase from 2022.
  • Axsome Therapeutics, Inc. annual Return On Assets for 2022 was -79.7 %, a 21.4% increase from 2021.
  • Axsome Therapeutics, Inc. annual Return On Assets for 2021 was -101 %, a 91.7% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43.7 +36 +45.1% Jan 1, 2023 Dec 31, 2023
2022 -79.7 +21.7 +21.4% Jan 1, 2022 Dec 31, 2022
2021 -101 -48.5 -91.7% Jan 1, 2021 Dec 31, 2021
2020 -52.9 +22.3 +29.7% Jan 1, 2020 Dec 31, 2020
2019 -75.2 +77.4 +50.7% Jan 1, 2019 Dec 31, 2019
2018 -153 -77.2 -102% Jan 1, 2018 Dec 31, 2018
2017 -75.4 -6.62 -9.63% Jan 1, 2017 Dec 31, 2017
2016 -68.7 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.